Ad
BLCM Quote Trading Chart Bellicum Pharmaceuticals Inc.
home / stock / blcm / blcm quote
$1.45 Last:
11.64% Change Percent:
$1.4708 Open:
$1.2988 Previous Close:
$1.5 High:
$1.44 Low:
36,371 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
BLCM Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-12 | 1.4708 | 1.2988 | 1.5 | 1.44 | 36,371 |
| 2022-08-11 | 1.34 | 1.2988 | 1.4373 | 1.335 | 19,509 |
| 2022-08-10 | 1.3773 | 1.2988 | 1.3773 | 1.33 | 17,177 |
| 2022-08-09 | 1.37 | 1.2988 | 1.37 | 1.33 | 9,195 |
| 2022-08-08 | 1.4 | 1.2988 | 1.4 | 1.32 | 18,935 |
| 2022-08-05 | 1.45 | 1.2988 | 1.45 | 1.32 | 55,572 |
| 2022-08-04 | 1.37 | 1.2988 | 1.55 | 1.37 | 33,686 |
| 2022-08-03 | 1.24 | 1.2988 | 1.5 | 1.24 | 75,284 |
| 2022-08-02 | 1.3 | 1.2988 | 1.37 | 1.3 | 22,960 |
| 2022-08-01 | 1.28 | 1.2988 | 1.32 | 1.28 | 5,647 |
| 2022-07-29 | 1.25 | 1.2988 | 1.32 | 1.25 | 10,818 |
| 2022-07-28 | 1.2988 | 1.2988 | 1.3 | 1.2401 | 17,457 |
| 2022-07-26 | 1.14 | 1.14 | 1.25 | 1.14 | 22,332 |
| 2022-07-25 | 1.2 | 1.22 | 1.2501 | 1.2 | 6,558 |
| 2022-07-19 | 1.12 | 1.17 | 1.18 | 1.12 | 8,685 |
| 2022-07-18 | 1.14 | 1.12 | 1.15 | 1.1 | 9,407 |
| 2022-07-15 | 1.14 | 1.194 | 1.21 | 1.13 | 23,479 |
| 2022-07-14 | 1.06 | 1.13 | 1.1919 | 1.06 | 14,361 |
| 2022-07-13 | 1.101 | 1.05 | 1.16 | 1.04 | 41,164 |
| 2022-07-12 | 1.16 | 1.06 | 1.21 | 1.06 | 46,246 |
Bellicum Pharmaceuticals Inc. Company Name:
BLCM Stock Symbol:
NASDAQ Market:
Bellicum Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
HOUSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financial results for the second quarter 2022 and provided an operational update. “We have c...
-
HOUSTON, May 12, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financial results for the first quarter 2022 and provided an operational update. “I am please...
-
Shares of Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) traded at a new 52-week high today of $23.11. This new high was reached on above average trading volume as 67.8 million shares traded hands, while the average 30-day volume is approximately 34,000 shares. Bellicum Pharmaceuticals Inc ...